Imaging Biomarkers Market, By Type (Reagents & Kits, Instruments & Systems, and Software & Services), By Technology, By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4531
|
Published Date
December 2025
|
Pages
396
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
The Imaging Biomarkers Market size was valued at US$ 13,678.45 Million in 2024, expanding at a CAGR of 12.5% from 2025 to 2032.
The imaging biomarkers market is experiencing rapid growth, driven by advancements in quantitative imaging, AI-powered analysis, and the rise of precision medicine. Imaging biomarkers allow for the noninvasive assessment of physiological, molecular, and structural processes, enhancing disease diagnosis, prognosis, and therapy monitoring. Key imaging modalities—including MRI, CT, PET, and ultrasound—are increasingly leveraged to extract measurable imaging metrics, which serve as surrogate endpoints in clinical trials and guide personalized treatment strategies. The global market was valued at around USD 13.9billion in 2024 and is projected to reach approximately USD 39.2billion by 2033, growing at a CAGR of over 12% through the forecast period, reflecting strong demand for early detection and precision diagnostics.
The market’s expansion is supported by rising demand for early disease detection, the growth of clinical research, and the integration of radiomics and machine learning technologies, which improve diagnostic accuracy and predictive analytics. However, market growth is restrained by the high costs of advanced imaging systems, the complexity and expense of biomarker validation, and the lack of standardized imaging protocols, which can hinder widespread clinical adoption.
Imaging Biomarkers Market- Market Dynamics
Advancements in Technology
The imaging biomarkers sector has experienced significant growth in recent years, driven by advances in molecular diagnostics and integration with imaging technologies. In March 2025, Cizzle Biotech launched the CIZ1B biomarker assay, a non-invasive blood test designed for early detection of lung cancer. This assay complements imaging-based diagnostic procedures, such as CT and PET scans, by identifying high-risk individuals earlier, enabling timely intervention and improving overall diagnostic accuracy. Furthermore, a strategic collaboration with iGenomeDX ensures scalable access to the assay across the United States, enhancing accessibility and supporting the combined use of molecular and imaging biomarkers. Such innovations exemplify the ongoing trend of leveraging multi-modal diagnostic approaches to improve patient outcomes and advance precision medicine.
Imaging Biomarkers Market- Segmentation Analysis:
The Global Imaging Biomarkers Market is segmented on the basis of Type, Technology, Application, End User, and Region.
The molecular diagnostics market is segmented based on type into reagents & kits, instruments & systems, and software & services. Reagents and kits dominate the market due to their high consumption and frequent use in routine diagnostic testing, making them essential for clinical laboratories and research institutions. Instruments and systems provide automation, precision, and reproducibility, supporting high-throughput workflows, while software and services enable efficient data analysis, workflow management, and integration across diagnostic platforms. According to the U.S. Centers for Disease Control and Prevention (CDC), the demand for molecular diagnostic testing has grown substantially, with over 500 million tests conducted annually in the United States, reflecting the critical role of reagents, instruments, and software in ensuring accurate and timely results.
Based on technology, the molecular diagnostics market is divided into PCR, next-generation sequencing (NGS), in situ hybridization, chips & microarrays, mass spectrometry, and other emerging technologies. PCR remains widely used for its rapid and reliable nucleic acid detection, while NGS enables comprehensive genomic profiling for precision medicine and research applications. In situ hybridization provides spatial analysis of tissue samples, and microarrays and mass spectrometry enhance multiplexing capabilities and analytical precision. Other specialized technologies support niche and emerging diagnostic applications, including liquid biopsies and point-of-care testing. Government health agencies, such as the U.S. Food and Drug Administration (FDA), report a growing emphasis on genomic testing and advanced molecular diagnostics, driven by precision medicine initiatives and regulatory support for early disease detection, with the global molecular diagnostics market projected to exceed $15 billion by 2025.
Imaging Biomarkers Market- Geographical Insights
In 2025, the Imaging Biomarkers market continues to display significant regional variation, with North America leading as the largest regional market, accounting for over 36% of global revenue share. The region’s dominance stems from advanced healthcare infrastructure, robust research and development activities, substantial government and publicprivate funding, and high demand for precision medicine applications. Strong investments from agencies such as the National Institutes of Health (NIH) and extensive integration of biomarkers in clinical research and therapeutic monitoring bolster adoption across hospitals, laboratories, and academic centers.
The Asia Pacific region is the fastest-growing market, fueled by rising healthcare expenditure, government initiatives to strengthen healthcare infrastructure, increasing prevalence of infectious and chronic diseases, and rapid technological advancements. Europe maintains a significant market presence, driven by growing research investments and an aging population, which collectively contribute to heightened demand for imaging biomarkers. Other regions, including Latin America and the Middle East & Africa, are experiencing steady growth due to improvements in healthcare infrastructure, increasing disease burden, and gradual adoption of advanced diagnostic technologies.
Imaging Biomarkers Market- Country Insights
The United States Imaging Biomarkers market has been experiencing robust growth, reflecting a significant CAGR. This expansion is primarily driven by advancements in diagnostic technologies, increasing demand for personalized medicine, and the rising incidence of cancer and infectious diseases. The U.S. healthcare system’s emphasis on early disease detection and precision medicine has contributed to the widespread adoption of imaging biomarkers across hospitals, diagnostic centers, and research institutions. Key technologies, including liquid biopsy and next-generation sequencing (NGS), are increasingly integrated to enhance diagnostic accuracy and facilitate targeted therapy selection, particularly in oncology. Furthermore, the growing prevalence of infectious diseases such as COVID-19, influenza, and HIV has heightened the demand for rapid, accurate, and noninvasive molecular testing, further supporting market growth.
Imaging Biomarkers Market- Competitive Landscape:
The Imaging Biomarkers market in 2025 is characterized by intense competition, led by major global players who drive innovation and market growth through diverse product portfolios, technological advancements, and strategic expansions. For example, in August 2024, Sysmex Corporation expanded its strategic alliance with QIAGEN to strengthen collaboration in genetic testing, spanning research and development, clinical trials, commercialization, and global sales. This partnership builds on their initial 2021 collaboration focused on cancer companion diagnostics using ultra-sensitive liquid biopsy NGS technology. Market participants are actively pursuing product launches, regulatory approvals, acquisitions, and strategic partnerships to enhance their global presence. Continuous R&D and collaborative efforts among key players enable the market to meet diverse clinical needs while advancing diagnostic precision and personalized medicine.
Recent Developments:
- March 2025: Danaher Corporation, through subsidiaries like Beckman Coulter, invested in automated and high-throughput molecular diagnostic solutions to support a broad range of clinical applications.
- February 2023: Becton Dickinson (BD) received FDA Emergency Use Authorization (EUA) for a molecular diagnostic test capable of detecting and differentiating COVID-19, influenza A/B, and respiratory syncytial virus (RSV). The test, designed for use on the BD MAX Molecular Diagnostic System, requires only a single nasal or nasopharyngeal swab sample, streamlining diagnostics in clinical settings.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IMAGING BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- BD
- Abbott
- F. Hoffmann-La Roche, Ltd.
- Agilent Technologies, Inc.
- Danaher Corporation
- Siemens Healthineers AG
- Agilent Technologies Inc.
- Hologic Inc. (Gen Probe)
- Sysmex Corporation
- Illumina Inc.
- Others
GLOBAL IMAGING BIOMARKERS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
- Reagents & Kits
- Instruments & Systems
- Software & Services
GLOBAL IMAGING BIOMARKERS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- PCR
- Next-Generation Sequencing (NGS)
- In Situ Hybridization
- Chips & Microarrays
- Mass Spectrometry
- Other Technologies
GLOBAL IMAGING BIOMARKERS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Oncology
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Others
- Infectious Disease
- Respiratory Infections
- Sexually Transmitted Infections
- Blood-borne Infections
- Tuberculosis & Non-tuberculous Mycobacteria
- Others
- Pharmacogenomics
- Microbiology
- Genetic Disease Screening
- Human Leukocyte Antigen Typing
- Blood Screening
- Others
GLOBAL IMAGING BIOMARKERS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Diagnostic & Reference Laboratories
- Academic & Research Institutes
- Other End Users
GLOBAL IMAGING BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Imaging Biomarkers Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Imaging Biomarkers Market Snippet by Type
2.1.2. Imaging Biomarkers Market Snippet by Technology
2.1.3. Imaging Biomarkers Market Snippet by Application
2.1.4. Imaging Biomarkers Market Snippet by End User
2.1.5. Imaging Biomarkers Market Snippet by Country
2.1.6. Imaging Biomarkers Market Snippet by Region
2.2. Competitive Insights
3. Imaging Biomarkers Key Market Trends
3.1. Imaging Biomarkers Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Imaging Biomarkers Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Imaging Biomarkers Market Opportunities
3.4. Imaging Biomarkers Market Future Trends
4. Imaging Biomarkers Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Imaging Biomarkers Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Imaging Biomarkers Market Landscape
6.1. Imaging Biomarkers Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Imaging Biomarkers Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
7.1.2. Reagents & Kits
7.1.3. Instruments & Systems
7.1.4. Software & Services
8. Imaging Biomarkers Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
8.1.2. PCR
8.1.3. Next-Generation Sequencing (NGS)
8.1.4. In Situ Hybridization
8.1.5. Chips & Microarrays
8.1.6. Mass Spectrometry
8.1.7. Other Technologies
9. Imaging Biomarkers Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
9.1.2. Oncology
9.1.2.1. Breast Cancer
9.1.2.2. Prostate Cancer
9.1.2.3. Colorectal Cancer
9.1.2.4. Others
9.1.3. Infectious Disease
9.1.3.1. Respiratory Infections
9.1.3.2. Sexually Transmitted Infections
9.1.3.3. Blood-borne Infections
9.1.3.4. Tuberculosis & Non-tuberculous Mycobacteria
9.1.3.5. Others
9.1.4. Pharmacogenomics
9.1.5. Microbiology
9.1.6. Genetic Disease Screening
9.1.7. Human Leukocyte Antigen Typing
9.1.8. Blood Screening
9.1.9. Others
10. Imaging Biomarkers Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
10.1.2. Hospitals
10.1.3. Diagnostic & Reference Laboratories
10.1.4. Academic & Research Institutes
10.1.5. Other End Users
11. Imaging Biomarkers Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Imaging Biomarkers Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Imaging Biomarkers Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Imaging Biomarkers Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Imaging Biomarkers Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Imaging Biomarkers Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Imaging Biomarkers Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. BD
12.2.2. Abbott
12.2.3. F. Hoffmann-La Roche, Ltd.
12.2.4. Agilent Technologies, Inc.
12.2.5. Danaher Corporation
12.2.6. Siemens Healthineers AG
12.2.7. Agilent Technologies Inc.
12.2.8. Hologic Inc. (Gen Probe)
12.2.9. Sysmex Corporation
12.2.10. Illumina Inc.
12.2.11. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IMAGING BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- BD
- Abbott
- F. Hoffmann-La Roche, Ltd.
- Agilent Technologies, Inc.
- Danaher Corporation
- Siemens Healthineers AG
- Agilent Technologies Inc.
- Hologic Inc. (Gen Probe)
- Sysmex Corporation
- Illumina Inc.
- Others
GLOBAL IMAGING BIOMARKERS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
- Reagents & Kits
- Instruments & Systems
- Software & Services
GLOBAL IMAGING BIOMARKERS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- PCR
- Next-Generation Sequencing (NGS)
- In Situ Hybridization
- Chips & Microarrays
- Mass Spectrometry
- Other Technologies
GLOBAL IMAGING BIOMARKERS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Oncology
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Others
- Infectious Disease
- Respiratory Infections
- Sexually Transmitted Infections
- Blood-borne Infections
- Tuberculosis & Non-tuberculous Mycobacteria
- Others
- Pharmacogenomics
- Microbiology
- Genetic Disease Screening
- Human Leukocyte Antigen Typing
- Blood Screening
- Others
GLOBAL IMAGING BIOMARKERS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Diagnostic & Reference Laboratories
- Academic & Research Institutes
- Other End Users
GLOBAL IMAGING BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
